Semaglutide

Drug / Medication

GLP-1 receptor agonist used for diabetes and obesity; long-acting variants lead to sustained appetite suppression; approved 2005 (diabetes) and 2014 (obesity).

Mentioned in 26 videos

Expert discussions of Semaglutide across 26 podcasts.

Build a research pod, ask cited questions across all of them, and connect it to Claude or ChatGPT.

Get Started Free